AR026768A1 - MOLECULES SIMILAR TO ANTAGONISTS OF INTERLEUKIN-1 RECEIVERS AND USES OF THE SAME - Google Patents
MOLECULES SIMILAR TO ANTAGONISTS OF INTERLEUKIN-1 RECEIVERS AND USES OF THE SAMEInfo
- Publication number
- AR026768A1 AR026768A1 ARP000106550A ARP000106550A AR026768A1 AR 026768 A1 AR026768 A1 AR 026768A1 AR P000106550 A ARP000106550 A AR P000106550A AR P000106550 A ARP000106550 A AR P000106550A AR 026768 A1 AR026768 A1 AR 026768A1
- Authority
- AR
- Argentina
- Prior art keywords
- interleukin
- antagonists
- receivers
- same
- polypeptides similar
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 102000000589 Interleukin-1 Human genes 0.000 title 1
- 108010002352 Interleukin-1 Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 229940119178 Interleukin 1 receptor antagonist Drugs 0.000 abstract 1
- 102000019223 Interleukin-1 receptor Human genes 0.000 abstract 1
- 108050006617 Interleukin-1 receptor Proteins 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La presente provee polipéptidos similares a antagonistas de receptores de interleukin-1 y moléculas de ácido nucleico que los condifican. La presentetambién provee agentes selectivos de enlace, vectores, células huésped y métodos para producir polipé tidos similares a antagonistas de receptores deinterleukin-1. La presente provee adicionalmente composiciones farmacéuticas y métodos para el diagnostico, tratamiento, mejora y/o prevencion de enfermedades,desordenes y condiciones asociadas con polip éptidos similares a antagonistas de receptores de interleukin-1.This provides polypeptides similar to antagonists of interleukin-1 receptors and nucleic acid molecules that condition them. The present also provides selective binding agents, vectors, host cells and methods for producing polypeptides similar to deinterleukin-1 receptor antagonists. This further provides pharmaceutical compositions and methods for the diagnosis, treatment, improvement and / or prevention of diseases, disorders and conditions associated with polypeptides similar to interleukin-1 receptor antagonists.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17019199P | 1999-12-10 | 1999-12-10 | |
| US18805300P | 2000-03-09 | 2000-03-09 | |
| US19452100P | 2000-04-04 | 2000-04-04 | |
| US19591000P | 2000-04-10 | 2000-04-10 | |
| US72458300A | 2000-11-28 | 2000-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026768A1 true AR026768A1 (en) | 2003-02-26 |
Family
ID=27538813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106550A AR026768A1 (en) | 1999-12-10 | 2000-12-11 | MOLECULES SIMILAR TO ANTAGONISTS OF INTERLEUKIN-1 RECEIVERS AND USES OF THE SAME |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1246844A1 (en) |
| JP (1) | JP3842647B2 (en) |
| AR (1) | AR026768A1 (en) |
| AU (1) | AU779534B2 (en) |
| MX (1) | MXPA02005775A (en) |
| TW (1) | TWI283683B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7282378B2 (en) * | 2016-12-07 | 2023-05-29 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド | IL-1Ra cDNA |
| CN113940308A (en) * | 2021-04-28 | 2022-01-18 | 重庆腾达牧业有限公司 | Dazu black goat breeding house feeding management method |
-
2000
- 2000-12-04 MX MXPA02005775A patent/MXPA02005775A/en not_active Application Discontinuation
- 2000-12-04 EP EP00982417A patent/EP1246844A1/en not_active Withdrawn
- 2000-12-04 JP JP2001543599A patent/JP3842647B2/en not_active Expired - Fee Related
- 2000-12-04 AU AU19450/01A patent/AU779534B2/en not_active Ceased
- 2000-12-08 TW TW089126233A patent/TWI283683B/en not_active IP Right Cessation
- 2000-12-11 AR ARP000106550A patent/AR026768A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU779534B2 (en) | 2005-01-27 |
| AU1945001A (en) | 2001-06-18 |
| TWI283683B (en) | 2007-07-11 |
| EP1246844A1 (en) | 2002-10-09 |
| MXPA02005775A (en) | 2003-10-14 |
| JP2003518371A (en) | 2003-06-10 |
| JP3842647B2 (en) | 2006-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP034772A (en) | MCH ANTAGONISTS AND ITS USE IN OBESITY TREATMENT | |
| PT1054887E (en) | BICYCLIC DERIVATIVES OF PYRIDINE AND PYRIMIDINE AS ANTAGONISTS OF NON-NEUROPEPTIDE RECEPTORS AND | |
| AR029199A1 (en) | DERIVATIVES OF ADENOSINA N6 HETEROCICLICO 5'-TIO- SUBSTITUTES AGONIST A1 PARTIAL OR TOTAL, ITS USES, AND THE PHARMACEUTICAL COMPOSITIONS | |
| BRPI0511477A (en) | compounds and compositions as modulators of ppar | |
| EA200101019A1 (en) | GLUCOCORTICOID RECEPTOR MODULATORS | |
| BRPI0512674A (en) | compounds and compositions as modulators of steroid hormone nuclear receptors | |
| SE0003984L (en) | Adenosine A3 receptor modulators | |
| MA29088B1 (en) | INDAZOLE-CARBOXAMIDE COMPOUNDS. | |
| PT804236E (en) | USE OF ANTI-TNF ANTIBODIES AS A MEDICATION FOR TREATMENT OF DISEASES WHICH INVOLVE A HIGH SERLE LEVEL OF INTERLEUKIN-6 | |
| BR0315234A (en) | Indole derivatives as beta-2 agonists | |
| MX9301348A (en) | NEW COMPOUNDS THAT HAVE PHARMACOLOGICAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM. | |
| UY24560A1 (en) | PIRIMIDINE ARYL DERIVATIVES USEFUL AS SELECTIVE 5HT2B ANTAGONISTS | |
| AR030236A1 (en) | MOLECULES SIMILAR TO IL-17 AND USES OF THE SAME | |
| BRPI0517015A (en) | compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| TR200101859T2 (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
| SV2003001148A (en) | DERIVATIVES OF BENZAMIDA TIAZOL AND PHARMACEUTICAL COMPOSTIONS TO INHIBIT THE PROLIFERATION OF CELLS, AND METHODS FOR ITS USE REF. NO.0097-01-SV | |
| AR030554A1 (en) | SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME | |
| GT200300294A (en) | INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES AND PROCEDURES FOR USE | |
| ES2196063T3 (en) | USE OF PROGESTERONE COMPETITIVE ANTAGONIST AGENTS FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DYSFUNCTIONAL UTERINE HEMORRAGIES. | |
| WO2005030678A3 (en) | AMINO-SUBSTITUTED ETHYLAMINO β2 ADRENERGIC RECEPTOR AGONISTS | |
| BRPI0415872A (en) | nucleic acids specifically binding to bioactive ghrelin | |
| BR9910130A (en) | Cuban derivatives as metabotropic glutamate receptor antagonists and process for their preparation | |
| BRPI0413013A (en) | compound, its salts, solvates, and pharmaceutically functional derivatives, pharmaceutical composition, use of a compound, and methods for the treatment or prophylaxis of conditions or disorders, and diseases | |
| ECSP003707A (en) | DIAZEPANES | |
| WO2003087338A3 (en) | Her-2 receptor tyrosine kinase molecules and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |